Epigénesis Genética; Regulación Neoplásica de la Expresión Génica; Melanoma/genética; Carcinogénesis/genética; Ensamble y Desensamble de Cromatina; Metilación de ADN; Histonas/metabolismo; Humanos; Melanoma/patología; Procesamiento Proteico-Postraduccional; Proto-Oncogenes Mas; ARN Largo no Codificante/metabolismo; Transducción de Señal

5hmC, 5-hydroxymethylcytosine; 5mC, 5-methylcytosine; ACE, angiotensin converting enzyme; ANCR, anti-differentiation non-coding RNA; ANRIL, antisense noncoding RNA in INK4 locus; ASK1, apoptosis signal-regulating kinase 1; ATRA, all-trans retinoic acid; BANCR, BRAF-activated non-coding RNA; BCL-2, B-cell lymphoma 2; BRAF, B-Raf proto-oncogene, serine/threonine kinase; BRG1, ATP-dependent helicase SMARCA4; CAF-1, chromatin assembly factor-1; CBX7, chromobox homolog 7; CCND1, cyclin D1; CD28, cluster of differentiation 28; CDK, cyclin-dependent kinase; CDKN2A/B, cyclin-dependent kinase inhibitor 2A/B; CHD8, chromodomain-helicase DNA-binding protein 8; CREB, cAMP response element-binding protein; CUDR, cancer upregulated drug resistant; Cdc6, cell division cycle 6; DNA methylation/demethylation; DNMT, DNA methyltransferase; EMT, epithelial-mesenchymal transition; ERK, extracellular signal-regulated kinase; EZH2, enhancer of zeste homolog 2; GPCRs, G-protein coupled receptors; GSK3a, glycogen synthase kinase 3 α; GWAS, genome-wide association study; HDAC, histone deacetylase; HOTAIR, HOX antisense intergenic RNA; IAP, inhibitor of apoptosis; IDH2, isocitrate dehydrogenase; IFN, interferon, interleukin 23; JNK, Jun N-terminal kinase; Jak/STAT, Janus kinase/signal transducer and activator of transcription; MAFG, v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G; MALAT1, metastasis-associated lung adenocarcinoma transcript 1; MAPK, mitogen-activated protein kinase; MC1R, melanocortin-1 receptor; MGMT, O6-methylguanine-DNA methyltransferase; MIF, macrophage migration inhibitory factor; MITF, microphthalmia-associated transcription factor; MRE, miRNA recognition element; MeCP2, methyl CpG binding protein 2; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NOD, nucleotide-binding and oligomerization domain; PBX, pre-B-cell leukemia homeobox; PEDF, pigment epithelium derived factor; PI3K, phosphatidylinositol-4, 5-bisphosphate 3-kinase; PIB5PA, phosphatidylinositol-4, 5-biphosphate 5-phosphatase A; PKA, protein kinase A; PRC, polycomb repressor complex; PSF, PTB associated splicing factor; PTB, polypyrimidine tract-binding; PTEN, phosphatase and tensin homolog; RARB, retinoic acid receptor-ß2; RASSF1A, Ras association domain family 1A; SETDB1, SET Domain, bifurcated 1; SPRY4, Sprouty 4; STAU1, Staufen1; SWI/SNF, SWItch/Sucrose Non-Fermentable; TCR, T-cell receptor; TET, ten eleven translocase; TGF ß, transforming growth factor ß; TINCR, tissue differentiation-inducing non-protein coding RNA; TOR, target of rapamycin; TP53, tumor protein 53; TRAF6, TNF receptor-associated factor 6; UCA1, urothelial carcinoma-associated 1; ceRNA, competitive endogenous RNAs; chromatin modification; chromatin remodeling; epigenetics; gene regulation; lncRNA, long ncRNA; melanoma; miRNA, micro RNA; ncRNA, non-coding RNA; ncRNAs; p14ARF, p14 alternative reading frame; p16INK4a, p16 inhibitor of CDK4; pRB, retinoblastoma protein; snoRNA, small nucleolar RNA; α-MSHm, α-melanocyte stimulating hormone